{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T12:45:13Z","timestamp":1784205913247,"version":"3.55.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1 CA79989"],"award-info":[{"award-number":["RO1 CA79989"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1016\/j.clim.2006.03.004","type":"journal-article","created":{"date-parts":[[2006,5,6]],"date-time":"2006-05-06T06:24:57Z","timestamp":1146896697000},"page":"33-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Role of indirect allo- and autoreactivity in anti-tumor responses induced by recipient leukocyte infusions (RLI) in mixed chimeras prepared with nonmyeloablative conditioning"],"prefix":"10.1016","volume":"120","author":[{"given":"Marie-Therese","family":"Rubio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiling","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Buchli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith","family":"Chittenden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Sykes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2006.03.004_bib1","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1182\/blood.V89.12.4531","article-title":"Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy","volume":"12","author":"Giralt","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.clim.2006.03.004_bib2","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1182\/blood.V98.13.3584","article-title":"Decreased transfusion requirements for patients receiving nonmyeloablative compared with conventional peripheral blood stem cell transplants from HLA-identical siblings","volume":"13","author":"Weissinger","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.clim.2006.03.004_bib3","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood.V91.3.756","article-title":"Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases","volume":"3","author":"Slavin","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.clim.2006.03.004_bib4","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1083-8791(00)70056-5","article-title":"Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies","volume":"3A","author":"Spitzer","year":"2000","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.clim.2006.03.004_bib5","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)11135-2","article-title":"Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation","volume":"9166","author":"Sykes","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.clim.2006.03.004_bib6","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1084\/jem.168.6.2391","article-title":"Graft-versus-host-related immunosuppression is induced in mixed chimeras by alloresponses against either host or donor lymphohematopoietic cells","volume":"6","author":"Sykes","year":"1988","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2006.03.004_bib7","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1053\/bbmt.1999.v5.pm10392959","article-title":"Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen","volume":"3","author":"Pelot","year":"1999","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.clim.2006.03.004_bib8","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1182\/blood-2002-01-0023","article-title":"Donor lymphocyte infusions mediate superior graft-versus-leukemia effects in mixed compared to fully allogeneic chimeras: a critical role for host antigen-presenting cells","volume":"5","author":"Mapara","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.clim.2006.03.004_bib9","series-title":"Autologous Bone Marrow Transplantation: Proceeding of the 10th International Symposium","first-page":"321","article-title":"Mixed lymphohematopoietic chimerism and delayed donor leukocyte infusions following non myeloablative conditioning and HLA-matched and mismatched donor bone marrow transplantation","author":"Spitzer","year":"2001"},{"key":"10.1016\/j.clim.2006.03.004_bib10","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0301-472X(03)00082-1","article-title":"Early host CD8 T-cell recovery and sensitized anti-donor interleukin-2-producing and cytotoxic T-cell responses associated with marrow graft rejection following nonmyeloablative allogeneic bone marrow transplantation","volume":"7","author":"Kraus","year":"2003","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.clim.2006.03.004_bib11","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1053\/bbmt.2001.v7.pm11760148","article-title":"Successful allogeneic stem cell transplantation with nonmyeloablative conditioning in patients with relapsed hematologic malignancy following autologous stem cell transplantation","volume":"11","author":"Dey","year":"2001","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.clim.2006.03.004_bib12","first-page":"672a","article-title":"Durable progression free survival (PFS) following non-myeloablative bone marrow transplantation (BMT) for chemorefractory diffuse large B cell lymphoma (B-LCL)","author":"Spitzer","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.clim.2006.03.004_bib13","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1097\/00007890-200211270-00011","article-title":"Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease","volume":"10","author":"Buhler","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.clim.2006.03.004_bib14","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S1083-8791(03)00077-6","article-title":"Impact of prophylactic donor leukocyte infusions on mixed chimerism, graft-versus-host disease, and antitumor response in patients with advanced hematologic malignancies treated with nonmyeloablative conditioning and allogeneic bone marrow transplantation","volume":"5","author":"Dey","year":"2003","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.clim.2006.03.004_bib15","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/00007890-199908270-00006","article-title":"Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohematopoietic chimerism","volume":"4","author":"Spitzer","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.clim.2006.03.004_bib16","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1097\/01.TP.0000064211.23536.AD","article-title":"Nonmyeloablative haploidentical stem-cell transplantation using anti-CD2 monoclonal antibody (MEDI-507)-based conditioning for refractory hematologic malignancies","volume":"10","author":"Spitzer","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.clim.2006.03.004_bib17","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2141.2004.05328.x","article-title":"Anti-tumour response despite loss of donor chimaerism in patients treated with non-myeloablative conditioning and allogeneic stem cell transplantation","volume":"3","author":"Dey","year":"2005","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.clim.2006.03.004_bib18","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1182\/blood-2002-12-3949","article-title":"Antitumor effect of donor marrow graft rejection induced by recipient leukocyte infusions in mixed chimeras prepared with nonmyeloablative conditioning: critical role for recipient-derived IFN-gamma","volume":"6","author":"Rubio","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.clim.2006.03.004_bib19","doi-asserted-by":"crossref","first-page":"665","DOI":"10.4049\/jimmunol.175.2.665","volume":"2","author":"Rubio","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2006.03.004_bib20","doi-asserted-by":"crossref","first-page":"549","DOI":"10.4049\/jimmunol.122.2.549","article-title":"Establishment and characterization of BALB\/c lymphoma lines with B cell properties","volume":"2","author":"Kim","year":"1979","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2006.03.004_bib21","first-page":"1068","article-title":"Eradication of residual disease by administration of leukemia-specific T cells after experimental allogeneic bone marrow transplantation","volume":"11","author":"Zeis","year":"1998","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.clim.2006.03.004_bib22","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1084\/jem.150.3.580","article-title":"Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors","volume":"3","author":"Unkeless","year":"1979","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2006.03.004_bib23","doi-asserted-by":"crossref","first-page":"352","DOI":"10.4049\/jimmunol.162.1.352","article-title":"Contributions of direct and indirect T cell alloreactivity during allograft rejection in mice","volume":"1","author":"Benichou","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2006.03.004_bib24","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nm0797-783","article-title":"Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myelosuppressive conditioning","volume":"7","author":"Sykes","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.clim.2006.03.004_bib25","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1053\/bbmt.2001.v7.pm11787527","article-title":"Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance","volume":"12","author":"Mapara","year":"2001","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.clim.2006.03.004_bib26","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/77793","article-title":"Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages","volume":"2","author":"Diefenbach","year":"2000","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2006.03.004_bib27","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.4049\/jimmunol.172.3.1333","article-title":"NK cell compartments and their activation by dendritic cells","volume":"3","author":"Ferlazzo","year":"2004","journal-title":"J. Immunol."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152166160600088X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152166160600088X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:55:21Z","timestamp":1761494121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152166160600088X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S152166160600088X"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2006.03.004","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of indirect allo- and autoreactivity in anti-tumor responses induced by recipient leukocyte infusions (RLI) in mixed chimeras prepared with nonmyeloablative conditioning","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2006.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}